Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interactionChangdong Lin, Jianfeng Chen, Jing Liu et al.|Signal Transduction and Targeted Therapy|2021Cited by 50
Distinct chemokines selectively induce HIV-1 gp120-integrin α4β7 binding via triggering conformer-specific activation of α4β7Shu Wang, Jianfeng Chen, Changdong Lin et al.|Signal Transduction and Targeted Therapy|2021Cited by 6
Correction To: Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interactionChangdong Lin, Jianfeng Chen, Guohui Li et al.|Signal Transduction and Targeted Therapy|2021Cited by 0